Familial X‐linked Addison disease as an expression of adrenoleukodystrophy (ALD)
- 1 May 1982
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 32 (5) , 543
- https://doi.org/10.1212/wnl.32.5.543
Abstract
Adrenoleukodystrophy (ALD) is a fatal X-linked disorder of very long chain fatty acid (VLCFA) metabolism manifested by disease of the central and peripheral nervous systems and the adrenals. X-linked Addison disease alone, as an expression of ALD, has not been previously reported. We present the results of our study of a unique family among whom clinically apparent Addison disease without neurologic involvement has occurred in affected males, and spastic para-paresis has occurred in female carriers. The presence of ALD was confirmed by VLCFA determination in cultured skin fibroblasts. A comparison group of patients with Addison disease on a putative immunopathogenic basis was normal.This publication has 8 references indexed in Scilit:
- AdrenoleukodystrophyNeurology, 1982
- Adrenoleukodystrophy: evidence for X linkage, inactivation, and selection favoring the mutant allele in heterozygous cells.Proceedings of the National Academy of Sciences, 1981
- The adrenoleukomyeloneuropathy complexNeurology, 1981
- High concentration of hexacosanoate in cultured skin fibroblast lipids from adrenoleukodystrophy patientsBiochemical and Biophysical Research Communications, 1978
- AdrenoleukodystrophyActa Neuropathologica, 1978
- AdrenomyeloneuropathyNeurology, 1977
- Histochemical characteristics of the striated inclusions of adrenoleukodystrophy.Journal of Histochemistry & Cytochemistry, 1976
- Qualitative alteration in substrate specificity of mitochondrial monoamine oxidase in brainJournal of Neurochemistry, 1976